Endocrinology policy updates
Track new and updated Endocrinology policies impacting reimbursement and clinical operations.
| Policy | Payer | Type | Specialty | Change | Effective |
|---|---|---|---|---|---|
| Intermittent Intravenous Insulin Therapy | Aetna | Clinical | Endocrinology | Modified | Dec 7, 2007 |
| Somatostatin Analogs | Aetna | Clinical | Endocrinology | Modified | Dec 7, 2004 |
| Zoledronic Acid | Aetna | Clinical | Endocrinology | Modified | Mar 12, 2002 |
| Thyrogen (Thyrotropin Alfa) | Aetna | Clinical | Endocrinology | Modified | Aug 21, 2001 |
| Growth Hormone (GH) and Growth Hormone Antagonists | Aetna | Clinical | Endocrinology | Modified | Aug 14, 1997 |
| Bone Mass Measurements | Aetna | Clinical | Endocrinology | Modified | Jul 16, 1996 |
| Diabetes Tests, Programs and Supplies | Aetna | Clinical | Endocrinology | Modified | Oct 20, 1995 |
| Nutritional Counseling | Aetna | Clinical | Endocrinology | Modified | Aug 3, 1995 |
| Implantable Hormone Pellets | Aetna | Clinical | Endocrinology | Modified | — |
| Prolia (denosumab) Injectable Medication Precertification Request — Coverage Criteria | Aetna | Clinical | Endocrinology | Modified | — |
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.
OpenPayer by Trek Health — Policy intelligence for billing and revenue cycle teams.
Coverage data is sourced from publicly available payer medical policy documents and updated as payers publish revisions. Read more about where our data comes from. Always consult the primary payer source for clinical decision-making.